| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 12/22/2009 | CA2492954C Pegylated t1249 polypeptide |
| 12/22/2009 | CA2487306C Novel piperidine compound |
| 12/22/2009 | CA2473662C Methods and compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin |
| 12/22/2009 | CA2444719C Method of production of an isomaltulose-containing enteral nutrient |
| 12/22/2009 | CA2406081C Administration of a thiol-based chemoprotectant compound |
| 12/22/2009 | CA2385860C Composition comprising casein protein and whey protein |
| 12/22/2009 | CA2361000C Urinary trypsin inhibitor to diagnose aids |
| 12/22/2009 | CA2357980C Malleable paste with allograft bone reinforcement for filling bone defects |
| 12/22/2009 | CA2354024C A recombinant vector expressing multiple costimulatory molecules and uses thereof |
| 12/22/2009 | CA2327465C Bipolar lipids capable of delivering polyanions to cells |
| 12/22/2009 | CA2323607C Immunological methods to modulate myostatin in vertebrate subjects |
| 12/22/2009 | CA2276267C Peptide-lipid conjugates, liposomes and liposomal drug delivery |
| 12/22/2009 | CA2234565C Specific antibodies for use in preparation of pharmaceutical compositions useful in the prevention or treatment of gastritis, gastric ulcers and duodenal ulcers |
| 12/22/2009 | CA2214636C Use of leukemia inhibitory factor and endothelin antagonists |
| 12/22/2009 | CA2185802C Hydrophobic drug delivery systems |
| 12/22/2009 | CA2183555C Reproduction and utilization of functional human tissue |
| 12/22/2009 | CA2180309C Coccidiosis poultry vaccine |
| 12/22/2009 | CA2173839C Transferrin compositions to alleviate the side effects of cytotoxic drugs |
| 12/22/2009 | CA2104871C Prad1 cyclin (cyclin d1) and its cdna |
| 12/19/2009 | CA2661953A1 Method, composition, and device, for the treatment of diseases, enzymes and saccharides disorders |
| 12/19/2009 | CA2654374A1 Method, composition, and device, for the treatment of diseases, enzymes and saccharides disorders |
| 12/19/2009 | CA2636864A1 Method, composition, and device, for the treatment of amylase activity malfunctions / inactivity in association with saccharides (mainly polysaccharides) based diseases |
| 12/17/2009 | WO2009152519A2 Novel antiviral peptides against influenza virus |
| 12/17/2009 | WO2009152518A1 Novel peptide adjuvant for influenza vaccination |
| 12/17/2009 | WO2009152493A2 Use of apolipoproteins to decrease inflammation |
| 12/17/2009 | WO2009152462A2 Method of regulating cell growth using a proteasome inhibitor |
| 12/17/2009 | WO2009152384A1 Solutions for tissue engineering and methods of use |
| 12/17/2009 | WO2009152247A2 Thrombopoietic activity of tyrosyl-trna synthetase polypeptides |
| 12/17/2009 | WO2009152152A1 Treatment of obesity with an interferon |
| 12/17/2009 | WO2009152128A1 Pegylated insulin lispro compounds |
| 12/17/2009 | WO2009152079A1 Melanocortin receptor-specific peptides for treatment of sexual dysfunction |
| 12/17/2009 | WO2009152051A1 Synthesis of a macrocyclic hcv protease inhibitor |
| 12/17/2009 | WO2009151907A2 Compositions and methods for using cells to treat heart tissue |
| 12/17/2009 | WO2009151788A2 Universal anchor peptide for nanoparticles |
| 12/17/2009 | WO2009151714A2 Therapeutic for treatment of circulatory shock, ischemia, inflammatory disease and related conditions |
| 12/17/2009 | WO2009151708A2 Peptide analogs of alpha-melanocyte stimulating hormone |
| 12/17/2009 | WO2009151698A1 Rapid assay for detecting ataxia-telangiectasia homozygotes and heterozygotes |
| 12/17/2009 | WO2009151691A2 Genetic polymorphisms associated wiith venous thrombosis, methods of detection and uses thereof |
| 12/17/2009 | WO2009151689A2 Improved beta thymosin fragments |
| 12/17/2009 | WO2009151634A1 Complement inhibitory agents as therapeutics in posttraumatic and degenerative arthritis |
| 12/17/2009 | WO2009151383A1 Melanocortin receptor-specific peptides for the treatment of obesity and other diseases associated with melanocortin receptor function |
| 12/17/2009 | WO2009151313A1 A novel antiviral peptide against avian influenza virus h9n2 |
| 12/17/2009 | WO2009151304A2 Composition comprised of akap12 and uses of akap12 mutant zebrafish as an animal model |
| 12/17/2009 | WO2009151288A2 Oligopeptide for enhancing osteointegration and osteogenesis |
| 12/17/2009 | WO2009150470A2 Suppression of cancers |
| 12/17/2009 | WO2009150469A2 Suppression of neuroendocrine diseases |
| 12/17/2009 | WO2009150371A2 Nanoparticles containing a peptide, vectors containing the same and pharmaceutical uses of said nanoparticles and said vectors |
| 12/17/2009 | WO2009150310A1 Use of the pat nonapeptide in the treatment of autoimmune diseases |
| 12/17/2009 | WO2009150253A1 Assessment of complications of patients with type 1 diabetes |
| 12/17/2009 | WO2009150252A2 Biotechnological production of cyanophycin dipeptides |
| 12/17/2009 | WO2009150249A1 Nt-probnp as prognostic indicator for the development of end stage renal disease in diabetes mellitus |
| 12/17/2009 | WO2009150214A2 Unacylated ghrelin and analogs as therapeutic agents for vascular remodeling in diabetic patients and treatment of cardiovascular disease |
| 12/17/2009 | WO2009150199A1 Conditioned medium of liver progenitor cells |
| 12/17/2009 | WO2009150194A1 Telaprevir dosing regimen |
| 12/17/2009 | WO2009150171A1 Method of treatment of inflammatory diseases |
| 12/17/2009 | WO2009150040A2 Opiorphin for use as a psychostimulant agent |
| 12/17/2009 | WO2009149931A2 Fatty acid binding protein in the pathogenesis of cardiac dysfunction |
| 12/17/2009 | WO2009149910A1 Anti-angiogenic compositions and therapeutic applications thereof |
| 12/17/2009 | WO2009149562A1 Compositions and methods for modulating nicotinic/nmda receptor function |
| 12/17/2009 | WO2009149560A1 Compositions and methods for modulating d1-d2 dopamine receptor interaction and function |
| 12/17/2009 | WO2009149554A1 Antimicrobial components of the mucus and extruded slime of hagfish (myxine glutinosa) |
| 12/17/2009 | WO2009149487A2 Compounds for treating symptoms associated with parkinson's disease |
| 12/17/2009 | WO2009149486A2 Compounds for treating diseases |
| 12/17/2009 | WO2009149485A2 Compounds for treating amyloidoses |
| 12/17/2009 | WO2009134917A3 Methods for treating inflammation |
| 12/17/2009 | WO2009130600A3 Therapeutic use of at least one botulinum neurotoxin in the treatment of pain associated with diabetic neuropathy |
| 12/17/2009 | WO2009120993A3 Synthetic analogs of the juxtamembrane domain of igf1r and uses thereof |
| 12/17/2009 | WO2009109532A3 Use of defensins against tuberculosis |
| 12/17/2009 | WO2009108762A3 Methods and compositions for treatment of retinoid-responsive conditions |
| 12/17/2009 | WO2009106532A3 Use of prokaryotic tir-domain containing proteins as therapeutic and diagnostic agents |
| 12/17/2009 | WO2009099677A3 Therapeutic peptidomimetic macrocycles |
| 12/17/2009 | WO2009087424A3 Proteinaceous compounds |
| 12/17/2009 | WO2009080778A3 Preparations with rosehip extracts, and method of producing rosehip extracts |
| 12/17/2009 | WO2009071460A3 New non-selective somatostatin analogues |
| 12/17/2009 | WO2009051706A3 Peptide compounds for treating obesity and insulin resistance |
| 12/17/2009 | WO2009046834A3 Use of t140 and optionally retrocyclin-1 as therapeutic agents for the treatment of m. tuberculosis infections |
| 12/17/2009 | WO2009043481A3 Use of adrenomedullin 13-52 and optionally retrocyclin-1 as a therapeutic agent for the treatment of hcmv infections |
| 12/17/2009 | WO2009043439A3 Use of retrocyclin- 1 as a therapeutic agent for the treatment of hcmv infections |
| 12/17/2009 | WO2009043437A3 Use of t140 and optionally retrocyclin-1 as therapeutic agents for the treatment of m. tuberculosis infections |
| 12/17/2009 | WO2009040072A3 Use of angiotensin i as a therapeutic agent in the treatment of eg aids or tuberculosis |
| 12/17/2009 | WO2009040071A3 Use of cyclo-rgdfv and optionally angiotensin i as therapeutic agents in the treatment of eg aids or tuberculosis |
| 12/17/2009 | WO2009040029A3 Use of adrenomedullin as a therapeutic agent for the treatment of excessive angiogenesis |
| 12/17/2009 | WO2009040028A3 Use of casoxin c and optionally adrenomedullin as therapeutic agents for the treatment of excessive angiogenesis |
| 12/17/2009 | WO2009039968A3 Use of angiotensin iii as a therapeutic agent in the treatment of eg hbv infection |
| 12/17/2009 | WO2009039966A3 Use of nf-kappab inhibitor sn50 and optionally angiotensin iii as therapeutic agents in the treatment of eg hbv infection |
| 12/17/2009 | WO2009039957A3 Use of angiotensin ii as a therapeutic agent in the treatment of eg s. pneumoniae infection |
| 12/17/2009 | WO2009033796A8 Use of a peptide as a therapeutic agent |
| 12/17/2009 | WO2009033707A3 Use of retrocyclin-1 as a therapeutic agent for the treatment of hcmv infections |
| 12/17/2009 | WO2009033661A3 Use of rgdspasskp and optionally angiotensin ii as therapeutic agents in the treatment of eg s. pneumoniae infections |
| 12/17/2009 | WO2009022068A3 Medicament for treating parkinson's disease |
| 12/17/2009 | WO2009022067A3 Medicament for treating parkinson's disease |
| 12/17/2009 | WO2008117125A3 Compositions capable of facilitating penetration across a biological barrier |
| 12/17/2009 | WO2006006195A9 Antibacterial peptides and analogues thereof |
| 12/17/2009 | US20090313721 Novel Bacillus Thuringiensis Gene with Lepidopteran Activity |
| 12/17/2009 | US20090313711 Novel protein and production process and use thereof |
| 12/17/2009 | US20090312540 Spatially-defined macrocycles incorporating peptide bond surrogates |
| 12/17/2009 | US20090312524 Compositions and methods comprising collagen |
| 12/17/2009 | US20090312403 Compositions and methods for wt1 specific immunotherapy |
| 12/17/2009 | US20090312400 Methods for Therapy of Neurodegenerative Disease of the Brain |
| 12/17/2009 | US20090312391 Unifying mechanism and methods to prevent cancer and neurodegenerative diseases |